The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
Open accessAbstract
Introduction Concerns with prescription antidepressant use in pregnant women have instigated the examination of potential associations between fetal exposure to antidepressant medication and outcomes including preterm delivery, congenital malformations, perinatal and post-natal adverse events, persistent pulmonary hypertension, and mortality. The retrospective cohort model is an often utilized study design. The objective of this review is to evaluate the literature on antidepressant use in pregnancy conducted as retrospective cohorts in national/regional medical, or claims databases that assess neonatal and infant outcomes for agreement between studies, ultimately providing a methodological and outcomes summary for future scientific endeavors.Methods PubMed was searched for literature relating to antidepressant use and infant outcomes from the earliest available date through July 15, 2016. Studies with a retrospective cohort design and conducted in national/regional medical or claims databases were included. Searched outcomes included preterm delivery, congenital malformations, low birth weight, small for gestational age, persistent pulmonary hypertension of the newborn, and other select adverse events comprising low Apgar score (5 min), convulsions/seizures, respiratory distress/problems, fetal mortality, and infant mortality.Results Of the 784 studies identified, 36 retrospective cohort studies met eligibility criteria. An increase in preterm delivery and respiratory distress/problems and no increase in congenital malformation or fetal and infant death were associated with prenatal use of prescription antidepressants by majority consensus (at least 2/3 [67%] of studies).Conclusions While consensus indicates that perinatal prescription antidepressant use has consequences for the fetus and infant, there are notable inconsistencies in the literature. More investigations that address prenatal exposure to depression and other important covariates are needed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cost:benefit ratio for medication shifts for peripartum depression given unclear evidence concerning safety during pregnancy.
“However, the cost:benefit ratio for medication shifts for PPD given unclear evidence concerning safety during the pregnancy,28”
Cites
Perinatal Depression: A Systematic Review of Prevalence and Incidence
Gavin, N. I., Gaynes, B. N., Lohr, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, T. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000183597.31630.db · Cited by 3,282 · see citing works
Australian and New Zealand Journal of Psychiatry
Skegg, K., Herbison, P., & Peter, K. S. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/(issn)1440-1614 · Cited by 1,264 · see citing works
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández–Dı́az, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.029 · Cited by 813 · see citing works
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551 · see citing works
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495 · see citing works
Increasing use of antidepressants in pregnancy
Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.033 · Cited by 458 · see citing works
(2015) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000465192.34779.dc · Cited by 424 · see citing works
Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
Huybrechts, K. F., Palmsten, K. K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M. K., Setoguchi, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312828 · Cited by 405 · see citing works
Use of antidepressant medications during pregnancy: a multisite study
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.036 · Cited by 403 · see citing works
Outcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 388 · see citing works
Reis, M., & Källén, B. A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709992194 · Cited by 339 · see citing works
Depression during Pregnancy: Overview of Clinical Factors
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424030-00004 · Cited by 317 · see citing works
Pedersen, L. H., Henriksen, T., Vestergaard, M., Olsen, J., & Bech, B. H. (2009) · BMJ · doi:10.1136/bmj.b3569 · Cited by 296 · see citing works
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B. A. J., & Wiholm, B. ‐. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284 · see citing works
Kieler, H., Artama, M., Engeland, A., Ericsson, Ö., Furu, K., Gissler, M., Nielsen, M. G., Nørgaard, M., Stephansson, O., Valdimarsdóttir, U. A., et al. (2011) · BMJ · doi:10.1136/bmj.d8012 · Cited by 276 · see citing works
Källén, B. A. J., & Olausson, P. O. (2007) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270 · see citing works
Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn
Huybrechts, K. F., Bateman, B. T., Palmsten, K. K., Desai, R. J., Patorno, E., Gopalakrishnan, C., Levin, R., Mogun, H., & Hernández–Dı́az, S. (2015) · JAMA · doi:10.1001/jama.2015.5605 · Cited by 254 · see citing works
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
Wen, S. W., Yang, Q., Garner, P. R., Fraser, W. D., Olatunbosun, O. A., Nimrod, C. A., & WALKER, M. C. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.019 · Cited by 235 · see citing works
Räisänen, S., Lehto, S. M., Nielsen, H. S., Gissler, M., Kramer, M. R., & Heinonen, S. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004883 · Cited by 222 · see citing works
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H. T., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211 · see citing works
Källén, B. A. J., & Olausson, P. O. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1570 · Cited by 205 · see citing works
Davis, R. L., Rubanowice, D. M., McPhillips, H. A., Raebel, M. A., Andrade, S. E., Smith, D. H., Yood, M. U., & Platt, R. G. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203 · see citing works
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
Andrade, S. E., McPhillips, H. A., Loren, D. J., Raebel, M. A., Lane, K., Livingston, J. M., Boudreau, D. M., Smith, D. H., Davis, R. L., Willy, M. E., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1710 · Cited by 195 · see citing works
Petersen, I., Gilbert, R. E., Evans, S. J. W., Man, S.-L., & Nazareth, I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06090blu · Cited by 192 · cited 1× · see citing works
“As pregnant women are much more likely to discontinue antidepressant use as compared to non-pregnant women [59], accurately measuring medication adherence is critical.”
Oberlander, T. F., Warburton, W. P., Misri, S. K., Riggs, W. K., Aghajanian, J., & Hertzman, C. (2008) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20144 · Cited by 186 · see citing works
Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L. H., Munk, E. M., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 184 · see citing works
Paroxetine in the first trimester and the prevalence of congenital malformations
Cole, J. A., Ephross, S. A., Cosmatos, I. S., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1463 · Cited by 163 · see citing works
Bupropion in pregnancy and the prevalence of congenital malformations
Cole, J. A., Modell, J. G., Haight, B. R., Cosmatos, I. S., Stoler, J. M., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1296 · Cited by 149 · see citing works
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies
Hayes, R. M., Wu, P., Shelton, R. C., Cooper, W. O., Dupont, W. D., Mitchel, E., & Hartert, T. V. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.028 · Cited by 149 · see citing works
Jimenez‐Solem, E., Andersen, J. T., Petersen, M. A., Broedbaek, K., Jensen, J. K., Afzal, S., Gislason, G., Torp-Pedersen, C. T., & Poulsen, H. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001148 · Cited by 140 · see citing works
Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression
Nordeng, H., van Gelder, M. M. H. J., Spigset, O., Koren, G., Einarson, A., & Eberhard‐Gran, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182490eaf · Cited by 133 · see citing works
Oberlander, T. F., Warburton, W. P., Misri, S. K., Aghajanian, J., & Hertzman, C. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037101 · Cited by 131 · see citing works
Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
Lennestål, R., & Källén, B. A. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4d2 · Cited by 129 · see citing works
Warburton, W. P., Hertzman, C., & Oberlander, T. F. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01490.x · Cited by 128 · see citing works
Antidepressants in pregnancy: a systematic review.
(2010) · PubMed · doi:10.3109/00048674.2010.507543 · Cited by 128 · see citing works
Antidepressant Use in Pregnant and Postpartum Women
Yonkers, K. A., Blackwell, K. A., Glover, J. G., & Forray, A. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153626 · Cited by 121 · see citing works
Zoëga, H., Kieler, H., Nørgaard, M., Furu, K., Valdimarsdóttir, U. A., Brandt, L., & Haglund, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144474 · Cited by 108 · see citing works
Furu, K., Kieler, H., Haglund, B., Engeland, A., Selmer, R., Stephansson, O., Valdimarsdóttir, U., Zoega, H., Artama, M., Gissler, M., et al. (2015) · British medical journal · doi:10.1136/bmj.h1798 · Cited by 102 · see citing works
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Stephansson, O., Kieler, H., Haglund, B., Artama, M., Engeland, A., Furu, K., Gissler, M., Nørgaard, M., Nielsen, R. B., Zoëga, H., et al. (2013) · JAMA · doi:10.1001/jama.2012.153812 · Cited by 100 · see citing works
Kelly, R. H., Danielsen, B. H., Golding, J. M., Anders, T. F., Gilbert, W. M., & Zatzick, D. (1999) · Psychiatric Services · doi:10.1176/ps.50.12.1584 · Cited by 98 · see citing works
Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome
Ewing, G., Tatarchuk, Y., Appleby, D. H., Schwartz, N., & Kim, D. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0233-3 · Cited by 97 · see citing works
Prevalence and predictors of antidepressant use in a cohort of pregnant women
Ramos, É., Oraichi, D., Rey, É., Blais, L., & Bérard, A. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01387.x · Cited by 95 · see citing works
The triad of substance abuse, violence, and depression are interrelated in pregnancy
Horrigan, T. J., Schroeder, A. V., & Schaffer, R. M. (2000) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(99)00058-6 · Cited by 94 · see citing works
Colvin, L., Slack-Smith, L. M., Stanley, F. J., & Bower, C. I. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20773 · Cited by 93 · see citing works
Antidepressant use during pregnancy: the benefit-risk ratio
Koren, G., & Nordeng, H. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.02.009 · Cited by 91 · see citing works
Pharmacogenetics and drug metabolism of newer antidepressant agents.
DeVane, C. L. (1994) · PubMed · Cited by 90 · see citing works
Suri, R., Lin, A. S., Cohen, L. S., & Altshuler, L. L. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08926 · Cited by 87 · see citing works
Sertraline use during pregnancy and the risk of major malformations
Bérard, A., Zhao, J., & Sheehy, O. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.01.034 · Cited by 85 · see citing works
Pregnancy‐induced changes in the pharmacokinetics of caffeine and its metabolites
Tian, Y., Campbell, S., Stockmann, C. R., Tak, C. R., Schoen, K., Clark, E., Varner, M. W., Spigarelli, M. G., & Sherwin, C. M. T. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.632 · Cited by 67 · see citing works
Self-citationSSRI Use During Pregnancy and Risk of Stillbirth and Neonatal Mortality
Jimenez‐Solem, E., Andersen, J. T., Petersen, M. A., Broedbaek, K., Lander, A. R., Afzal, S., Torp-Pedersen, C. T., & Poulsen, H. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081251 · Cited by 60 · see citing works
The effect of perinatal exposures on the infant: Antidepressants and depression
Hanley, G. E., & Oberlander, T. F. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.09.001 · Cited by 56 · see citing works
Margulis, A., Abou-Ali, A., Strazzeri, M. M., Ding, Y., Kuyateh, F., Frimpong, E., Levenson, M. S., & Hammad, T. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3462 · Cited by 56 · see citing works
Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth
Einarson, A., Choi, J., Einarson, T. R., & Koren, G. (2009) · Depression and Anxiety · doi:10.1002/da.20598 · Cited by 54 · see citing works
Zhao, Y., Hébert, M. F., & Venkataramanan, R. (2014) · Seminars in Perinatology · doi:10.1053/j.semperi.2014.08.011 · Cited by 51 · see citing works
Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31826686bc · Cited by 49 · see citing works
Källén, B. A. J., Nilsson, E. M. E., & Olausson, P. O. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1021-8 · Cited by 48 · see citing works
Maternal depression, antidepressant use in pregnancy and Apgar scores in infants
Jensen, H. M., Gr⊘n, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.115931 · Cited by 42 · see citing works
Sutter‐Dallay, A., Balès, M., Pambrun, É., Glangeaud-Freudenthal, N. M.-C., Wisner, K. L., & Verdoux, H. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09070 · Cited by 41 · see citing works
Obstetric Clinical Pharmacology: Coming of Age
Zajicek, A., & Giacoia, G. P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100136 · Cited by 40 · see citing works
Swanson, S. A., Hernández–Dı́az, S., Palmsten, K. K., Mogun, H., Olfson, M., & Huybrechts, K. F. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3798 · Cited by 37 · see citing works
Early Morbidity and Mortality Following In Utero Exposure to Selective Serotonin Reuptake Inhibitors
Colvin, L., Slack-Smith, L. M., Stanley, F. J., & Bower, C. I. (2012) · CNS Drugs · doi:10.2165/11634190-000000000-00000 · Cited by 30 · see citing works
Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years
Sundell, K. A., Gissler, M., Petzold, M., & Wærn, M. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0933-z · Cited by 30 · see citing works
Jensen, H. M., Grøn, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3029-5 · Cited by 29 · see citing works
The Problem of Confounding in Studies of the Effect of Maternal Drug Use on Pregnancy Outcome
Källén, B. A. J. (2011) · Obstetrics and Gynecology International · doi:10.1155/2012/148616 · Cited by 27 · see citing works
Promise and pitfalls of administrative data in evaluating pregnancy outcomes
Andrews, E. B., & Tennis, P. S. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1499 · Cited by 23 · see citing works
Symptoms of Depression Predict Negative Birth Outcomes in African American Women: A Pilot Study
Giurgescu, C., Engeland, C. G., & Templin, T. (2015) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12337 · Cited by 22 · see citing works
Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period
McDonagh, M. S., Matthews, A. M., Phillipi, C. A., Romm, J., Peterson, K., Thakurta, S., & Guise, J. (2014) · doi:10.23970/ahrqepcerta216 · Cited by 19 · see citing works
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov
Stockmann, C. R., Sherwin, C. M. T., Koren, G., Campbell, S., Constance, J. E., Linakis, M. W., Balch, A. H., Varner, M. W., & Spigarelli, M. G. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.212 · Cited by 18 · see citing works
Self-citationAre women with major depression in pregnancy identifiable in population health data?
Colvin, L., Slack-Smith, L. M., Stanley, F. J., & Bower, C. I. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-63 · Cited by 14 · see citing works
Broudy, C. A., & Payne, J. G. (2013) · Human Reproduction · doi:10.1093/humrep/det007 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Anderson, K. N., Lind, J. N., Simeone, R. M., Bobo, W. V., Mitchell, A. A., Riehle‐Colarusso, T. J., Polen, K. N. D., & Reefhuis, J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2453 · Cited by 141 · see citing works
Placental Complications Associated With Psychostimulant Use in Pregnancy
Cohen, J. M., Hernández–Dı́az, S., Bateman, B. T., Park, Y., Desai, R. J., Gray, K. J., Patorno, E., Mogun, H., & Huybrechts, K. F. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002362 · Cited by 80 · see citing works
Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression
Ko, Y., Kim, S., Lee, S., & Jang, C. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01292-5 · Cited by 64 · see citing works
Wang, J., & Cosci, F. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000516031 · Cited by 46 · see citing works
Pettman, D., O'Mahen, H., Skoog Svanberg, A., von Essen, L., Axfors, C., Blomberg, O., & Woodford, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032659 · Cited by 24 · see citing works
Jordan, S. E., Davies, G. I., Thayer, D. S., Tucker, D., & Humphreys, I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225133 · Cited by 39 · see citing works
Sharma, G. V., Gaffey, A. E., Hameed, A., Kasparian, N. A., Mauricio, R., Marsh, E. B., Beck, D., Skowronski, J. N., Wolfe, D. S., & Levine, G. N. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041369 · Cited by 39 · see citing works
Selecting a pharmacotherapy regimen for patients with chronic insomnia
Hassinger, A. B., Bletnisky, N., Dudekula, R., & El-Solh, A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1743265 · Cited by 32 · see citing works
Pharmacologic Treatment of Sleep Disorders in Pregnancy
McLafferty, L. P., Spada, M. L., & Gopalan, P. R. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.02.004 · Cited by 18 · see citing works
Coulson, C. C., Lorencz, E., Rittenhouse, K., Ramage, M., Lorenz, K., & Galvin, S. L. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1694729 · Cited by 18 · see citing works
Smith, S. J., Martin, F. Z., Rai, D., & Forbes, H. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2023-074600 · Cited by 18 · see citing works
The Use of Antidepressant Medications During Pregnancy and the Risk of Neonatal Seizures
Uğuz, F. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001093 · Cited by 13 · see citing works
Ankarfeldt, M. Z., Petersen, J., Andersen, J. T., Fernandes, M. F. S., Li, H., Motsko, S. P., Fast, T., & Jimenez‐Solem, E. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-022-00334-2 · Cited by 10 · see citing works
Li, D., Ferber, J. R., Odouli, R., Quesenberry, C. P., & Avalos, L. A. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.08.046 · Cited by 7 · see citing works
Tanguay, N., Abdelouahab, N., Simard, M., Séguin, J. R., Marc, I., Herba, C. M., MacLeod, A. A. N., Courtemanche, Y., Fraser, W. D., & Muckle, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1252251 · Cited by 7 · see citing works
Galvin, S. L., Ramage, M., Mazure, E. S., & Coulson, C. C. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108098 · Cited by 7 · see citing works
Lee, K. C. K., Fung, V. S. C., Chan, J. K. N., Wong, C. S. M., Cheung, K. W., Seto, M. T. Y., Lin, J., & Chang, W. C. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.05.001 · Cited by 6 · see citing works
Pharmacologic Treatment of Sleep Disorders in Pregnancy
McLafferty, L. P., Spada, M. L., & Gopalan, P. R. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.06.009 · Cited by 7 · see citing works
Laine, M. K., Masalin, S., Rönö, K., Kautiainen, H., Gissler, M., Pennanen, P., & Eriksson, J. G. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1534265 · Cited by 4 · see citing works
Moore, V., Rumbold, A. R., Fernandez, R. C., McElroy, H. J., Moore, L., Giles, L. C., Grzeskowiak, L. E., Roughead, E. E., Stark, M. J., Russell, D. L., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae741 · Cited by 3 · see citing works
Smith, S., Martin, F. Z., Rai, D., & Forbes, H. J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4046664 · Cited by 2 · see citing works
Sleep disorders during pregnancy
Shkurenko, Y. V., Ибатов, А. Д., Alieva, U. E., Trofimova, S. Y., & Einullaeva, S. E. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412405299 · Cited by 1 · see citing works
Li, D., Ferber, J. R., Odouli, R., FLANAGAN, T. A., Avalos, L. A., Turner, M., & Quesenberry, C. P. (2020) · doi:10.25302/03.2020.ce.13046721
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Anisman, H., Hayley, S. P., & Kusnecov, A. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00006-5
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Neonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Aref, L., Hughey, J., Shirazi, S. M., Sucre, J. M. S., & Bastarache, L. A. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.22790
- Authors
- Tak, C. R., Job, K. M., Schoen-Gentry, K., Campbell, S. C., Carroll, P., Costantine, M., Brixner, D., Birnbaum, A. K., & Sherwin, C. M. T.
- Affiliations
- University of Utah (US)
- Intermountain Healthcare (US)
- The University of Texas Medical Branch at Galveston (US)
- University of Minnesota (US)
- Corresponding author
- Sherwin, Catherine M. T.
- ORCID
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2017-06-09
- Volume
- 73
- Issue
- 9
- Pages
- 1055-1069
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2622412817
- Cited by
- 27
- References
- 70
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 1
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- green
- works.bepress.com
- Licence
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- CORE Scholar (Wright State University) (submittedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- antidepressant use in pregnancy, prenatal drug exposure, neonatal outcomes, preterm birth, congenital malformations, persistent pulmonary hypertension of the newborn, low birth weight, small for gestational age, infant mortality, respiratory distress, Apgar score, maternal depression
- MeSH terms
- Congenital Abnormalities, Antidepressive Agents, Female, Humans, Hypertension, Pulmonary, Infant, Low Birth Weight, Infant, Newborn, Obstetric Labor, Premature, Pregnancy, Respiration Disorders, Seizures, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
